Delivering reliable patient access, experienced investigators, and efficient trial execution in the heart of San Antonio, Texas.
Delivering reliable patient access, experienced investigators, and efficient trial execution in the heart of San Antonio, Texas.
San Antonio Clinical Trials is a dedicated multi-specialty clinical research site in San Antonio, Texas, serving a diverse adult population across the greater San Antonio region. With two board-certified principal investigators spanning endocrinology, cardiology, gastroenterology, and dermatology, our site offers sponsors and CROs a reliable clinical research center in San Antonio TX they can count on.
As a proud member of ECN Clinical, San Antonio Clinical Trials operates under centralized SOPs, unified contracting, and network-wide quality standards, giving sponsors the consistency of a national network with the accountability of a dedicated local site.
San Antonio Clinical Trials conducts clinical research across six therapeutic areas led by two board-certified principal investigators. Dr. Dempsey Gordon Jr. brings deep expertise in endocrinology clinical research, cardiovascular clinical research, and gastroenterology clinical research in San Antonio. Dr. Mary Ramirez brings specialized expertise in dermatology, family medicine, and internal medicine, including diabetes clinical research in San Antonio.
Our patient recruitment infrastructure combines technology, community relationships, and dedicated outreach to deliver consistent enrollment performance across every study we support.
San Antonio Clinical Trials serves a diverse adult and geriatric population ranging from 18 to over 80 years old across San Antonio and the surrounding Texas region. Our Babcock Road location gives participants from across the greater San Antonio area a convenient clinical research site near them, with a fully bilingual team and patient-first care model throughout every study.
Our San Antonio location gives San Antonio Clinical Trials access to one of Texas's most diverse communities. With a patient population that is 47% Hispanic/Latino, our fully bilingual English and Spanish team removes communication barriers and ensures every participant feels fully informed and supported throughout their study journey.
Diversity in clinical research is a commitment to the communities we serve. Our sites are chosen and structured to reflect the communities they serve, ensuring every study benefits from genuine local representation, trust, and accessibility.
Our network capability deck or TA-specific one-pagers to share with your team.
Yes. San Antonio Clinical Trials offers paid clinical research opportunities in San Antonio and across the greater Texas region. Compensation varies by study and will be explained clearly before you enroll. Study-related medical care and visits are always at no cost to participants.
San Antonio Clinical Trials is located at 5441 Babcock Rd., Suite 203, San Antonio, Texas 78240, serving participants across a 40-mile catchment radius throughout the greater San Antonio region.
San Antonio Clinical Trials is a CLIA-certified clinical research site in San Antonio TX offering Phase II through IV capabilities. Our site includes onsite ECG, temperature-controlled drug storage, DEA licensing, CTMS and multiple EDC platforms, eConsent, cold chain storage, and specialty procedures including biopsies, PK sampling, spirometry, oscillometry, FeNO, and certified FibroScan.
San Antonio Clinical Trials conducts endocrinology clinical research, diabetes clinical research, cardiovascular clinical research, gastroenterology clinical research, and dermatology clinical research in San Antonio, led by two board-certified principal investigators across six therapeutic areas.
Yes. San Antonio Clinical Trials is a dedicated clinical research site for sponsors and CROs, operating as part of the ECN Clinical under centralized SOPs, unified contracting, and network-wide quality standards. Sponsors and CROs benefit from a proven 85% screen to enroll rate, 91% patient retention rate, and startup timelines consistently under 4 weeks.
